JD vs PPCB · P/E 7.6, rev $187.20B vs P/E 0.0, $3.9M cap
JD.com Inc Adr (JD) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
PPCB does not have a complete income-statement cache yet.
JD currently screens at market cap $45.56B and trailing P/E 7.6. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the JD and PPCB stock pages for the full models.
Not investment advice.